Cleo Investor Webinar - an update on the Company’s progress and commercialisation pathway

Investor Webinar
Written By Andrew ZAPPIA

Cleo’s Chief Executive Officer, Richard Allman and Chief Scientific Officer, Andrew Stephens, provide an update on the Company’s progress and commercialisation pathway.

Andrew ZAPPIA
Previous

CLEO Strengthens FDA Submission Following Access to Globally Respected U.S. Biobank
Next

CLEO Advances Commercial Product Development with Completion of Alpha Testing